STAT3-shRNAs promote HBV positive HCC cell apoptosis, and suppresses HBV replication, which broke HBV-STAT3 signaling loop and augment STAT3-shRNAs-mediated anti-HCC effect (Yang et al., 2016). This evidence concerns the gene STAT3 and hepatocellular carcinoma.